Pimavanserin is an atypical antipsychotic medication indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. As a selective serotonin 5-HT2A receptor… Read more





![Chemical structure of 1,1-bis[(4-Fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2518374-84-8-11-bis4-Fluorophenylmethyl-3-4-isobutoxyphenylmethylurea.png&w=3840&q=75)



![Chemical structure of 1-(4-Fluorophenyl)-N-[(4-fluorophenyl)methyl]methanimine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F428819-12-9-1-4-Fluorophenyl-N-4-fluorophenylmethylmethanimine.png&w=3840&q=75)

![Chemical structure of 1-[(4-Fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)isourea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-4-Fluorophenylmethyl-3-4-isobutoxyphenylmethyl-1-1-methyl-4-piperidylisourea.png&w=3840&q=75)
![Chemical structure of 1-[(4-Fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(4-piperidyl)urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F639863-77-7-1-4-Fluorophenylmethyl-3-4-isobutoxyphenylmethyl-1-4-piperidylurea.png&w=3840&q=75)
![Chemical structure of 1-[(4-Fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1388858-78-3-1-4-Fluorophenylmethyl-3-4-isobutoxyphenylmethylurea.png&w=3840&q=75)
![Chemical structure of 1-[(4-Hydroxyphenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2514955-82-7-1-4-Hydroxyphenylmethyl-3-4-isobutoxyphenylmethyl-1-1-methyl-4-piperidylurea.png&w=3840&q=75)

![Chemical structure of 1-Benzyl-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2512201-55-5-1-Benzyl-3-4-isobutoxyphenylmethyl-1-1-methyl-4-piperidylurea.png&w=3840&q=75)







![Chemical structure of 4-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-E-1-methyl-4-piperidyliminomethylphenol.png&w=3840&q=75)
![Chemical structure of 4-Fluoro-N,N-bis[(4-fluorophenyl)methyl]- benzenemethanamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F932724-63-5-4-Fluoro-NN-bis4-fluorophenylmethyl-benzenemethanamine.png&w=3840&q=75)







![Chemical structure of N,N-bis[(4-Fluorophenyl)methyl]piperidin-4-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2514763-52-9-NN-bis4-Fluorophenylmethylpiperidin-4-amine.png&w=3840&q=75)










Pimavanserin is an atypical antipsychotic medication indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. As a selective serotonin 5-HT2A receptor inverse agonist and antagonist, it functions by targeting specific serotonin pathways without blocking dopamine receptors, thereby preserving motor function. The Pimavanserin category includes a comprehensive range of high-quality reference standards essential for pharmaceutical research, quality control, and regulatory compliance. These products encompass the active pharmaceutical ingredient, as well as its related process impurities, degradation products, and metabolites. Laboratories utilize these compounds for precise impurity profiling, analytical method development, and validation to ensure drug safety and efficacy. Additionally, stable isotope labelled compounds are available to provide internal standards for accurate quantification in complex matrices during bioanalytical studies. These materials support rigorous stability testing and help maintain consistent quality standards throughout the pharmaceutical lifecycle.